iCo Therapeutics Announces World Wide Exclusive Option and EU License Rights with Laboratorios SALVAT for Novel Glaucoma Asset
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2016) - iCo Therapeutics (TSXV: ICO) (OTCQX: ICOTF) ("iCo" or "the Company"), today announced a World Wide Exclusive Option and EU License Rights with Laboratorios SALVAT for a Novel Glaucoma Asset.Highlights:Glaucoma candidate a novel and potentially first in class assetSalvat to market glaucoma drug in EU with iCo receiving royaltiesExclusive option to acquire asset outright over multiple development stage milestonesaggregate...
2016-11-15 8:00 AM EST
iCo Therapeutics Announces Second Quarter 2016 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2016) - iCo Therapeutics (TSXV: ICO) (OTCQX: ICOTF) ("iCo" or "the Company"), today reported financial results for the quarter ended June 30, 2016. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS")."Our second quarter results attest to the substantive conclusion of our reorganization, reducing the loss for the Q2 2016 period by roughly 74%...
2016-08-19 4:00 PM EDT
iCo Therapeutics Announces Voting and Election Results from Annual Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2016) - iCo Therapeutics (TSXV: ICO) (OTCQX: ICOTF) ("iCo" or "the Company"), today announced that all nominees listed in the management information circular dated May 30, 2016 were elected as directors at its 2016 Annual Meeting of Shareholders, held on June 24 2016. On a vote by ballot, the following 4 nominees proposed by management were elected as Directors of iCo Therapeutics to serve until the Company's next Annual Meeting of...
2016-06-27 4:30 PM EDT
IIROC Trade Resumption - iCo Therapeutics Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2014) - Trading resumes in: Company: iCo Therapeutics Inc.
2014-01-27 10:18 AM EST
IIROC Trade Halt - iCo Therapeutics Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2014) - The following issues have been halted by IIROC:Company: iCo Therapeutics Inc.
2014-01-27 9:30 AM EST